Financial Year |
March 31 2023 |
Monetary Funds |
3,860,233,128.09 |
Held-for-trading Financial Assets |
87,892,810.27 |
Notes Receivable |
50,000.00 |
Accounts Receivable |
1,489,069,319.82 |
Advances to Suppliers |
433,797,032.08 |
Other Receivables |
381,675,767.31 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,323,782,168.99 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
107,653,856.01 |
Total Current Assets |
9,632,989,620.94 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
2,039,468,381.57 |
Investment Properties |
8,613,074.10 |
Fixed Assetes |
23,286,292,481.68 |
Under-construction Projects |
3,122,695,185.03 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,479,732,954.57 |
R&D expenses |
-- |
Goodwill |
948,154,596.35 |
Long-Term Deferred and Prepaid Expenses |
255,010,853.66 |
Deferred Income Tax Assets |
249,571,102.12 |
Other Non-Current Assets |
420,561,165.64 |
Sub-Total of Non-Current Assets |
32,908,870,555.48 |
Total Assets |
42,541,860,176.42 |
Short-Term Loans |
1,840,148,868.41 |
Trading Financial liabilities |
-- |
Notes Payable |
502,630,435.06 |
Accounts Payable |
4,591,402,730.55 |
Accounts Received In Advance |
73,666,968.35 |
Employee Compensation Payable |
224,143,215.54 |
Taxes Payable |
576,810,956.32 |
Interest Payable |
-- |
Dividend Payable |
1,685,999.90 |
Other payables |
403,087,991.12 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,400,533,136.38 |
Other Current Liabilities |
59,028,667.47 |
Sub-Total of Current Liabilities |
10,206,900,838.63 |
Long-term Loans |
5,952,751,308.06 |
Bonds Payable |
2,654,390,726.59 |
Long-Term Accounts Payable |
500,918,859.74 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
433,958,918.78 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
10,312,785,657.56 |
Total Liabilities |
20,519,686,496.19 |
Paid-In Capital(Or Share Stock) |
1,111,670,663.00 |
Capital Surplus |
7,180,959,561.77 |
Surplus Reserve |
865,811,535.50 |
LESS:Treasury Stock |
29,685,660.00 |
Undistributed Profits |
11,634,577,891.83 |
Minority Stockholder's Interest |
1,054,746,814.77 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,967,426,865.46 |
Owner's Equity(Stockholder's Equity) |
22,022,173,680.23 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
42,541,860,176.42 |